• Home
  • Search Results
  • Seipin Facilitates Triglyceride Flow to Lipid Droplet and Counteracts Droplet Ripening via Endoplasmic Reticulum Contact.

Seipin Facilitates Triglyceride Flow to Lipid Droplet and Counteracts Droplet Ripening via Endoplasmic Reticulum Contact.

Developmental cell (2019-06-11)
Veijo T Salo, Shiqian Li, Helena Vihinen, Maarit Hölttä-Vuori, Abel Szkalisity, Peter Horvath, Ilya Belevich, Johan Peränen, Christoph Thiele, Pentti Somerharju, Hongxia Zhao, Alexandre Santinho, Abdou Rachid Thiam, Eija Jokitalo, Elina Ikonen
ABSTRACT

Seipin is an oligomeric integral endoplasmic reticulum (ER) protein involved in lipid droplet (LD) biogenesis. To study the role of seipin in LD formation, we relocalized it to the nuclear envelope and found that LDs formed at these new seipin-defined sites. The sites were characterized by uniform seipin-mediated ER-LD necks. At low seipin content, LDs only grew at seipin sites, and tiny, growth-incompetent LDs appeared in a Rab18-dependent manner. When seipin was removed from ER-LD contacts within 1 h, no lipid metabolic defects were observed, but LDs became heterogeneous in size. Studies in seipin-ablated cells and model membranes revealed that this heterogeneity arises via a biophysical ripening process, with triglycerides partitioning from smaller to larger LDs through droplet-bilayer contacts. These results suggest that seipin supports the formation of structurally uniform ER-LD contacts and facilitates the delivery of triglycerides from ER to LDs. This counteracts ripening-induced shrinkage of small LDs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Oleic acid, suitable for cell culture, BioReagent
Sigma-Aldrich
Indole-3-acetic acid sodium salt, suitable for plant cell culture, BioReagent, ≥98%
Triolein, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
PF-06424439, ≥98% (HPLC)
Sigma-Aldrich
PF-04620110, ≥98% (HPLC)
Sigma-Aldrich
Anti-Rab18 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
Sigma-Aldrich
MISSION® esiRNA, targeting human ACSL3
Sigma-Aldrich
MISSION® esiRNA, targeting human PNPLA2

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.